Best practices for long-term monitoring and follow-up of alemtuzumab-treated MS patients in real-world clinical settings

Autor:	Barclay, Kate, Carruthers, R, Traboulsee, A, Bass, AD, LaGanke, C, Bertolotto, Antonio, Boster, A, Celius, Elisabeth Gulowsen, deSeze, J, Cruz, DD, Habek, Mario, Lee, JM, Limmroth, V, Meuth, SG, Oreja-Guevara, Celia, Pagnotta, P, Vos, Christine, Ziemssen, Tjalf, Baker, DP, Wijmeersch, BV
Zdroj:	Barclay, Kate Carruthers, R Traboulsee, A Bass, AD LaGanke, C Bertolotto, Antonio Boster, A Celius, Elisabeth Gulowsen deSeze, J Cruz, DD Habek, Mario Lee, JM Limmroth, V Meuth, SG Oreja-Guevara, Celia Pagnotta, P Vos, Christine Ziemssen, Tjalf Baker, DP Wijmeersch, BV . Best practices for long-term monitoring and follow-up of alemtuzumab-treated MS patients in real-world clinical settings. Frontiers in Neurology. 2019, 10 Frontiers in Neurology
Databáze:	NORA (Norwegian Open Research Archive)
Externí odkaz:	http://hdl.handle.net/10852/76417 https://www.duo.uio.no/bitstream/handle/10852/76417/2/Barclay%2Bfneur-10-00253.pdf Zobrazit plný text záznamu